Annual ROE
-35.92%
+65.05%+64.43%
December 31, 2023
Summary
- As of February 7, 2025, DNTH annual return on equity is -35.92%, with the most recent change of +65.05% (+64.43%) on December 31, 2023.
- During the last 3 years, DNTH annual ROE has fallen by -111.92% (-147.26%).
- DNTH annual ROE is now -147.26% below its all-time high of 76.00%, reached on December 31, 2021.
Performance
DNTH ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-23.69%
+0.92%+3.74%
September 30, 2024
Summary
- As of February 7, 2025, DNTH quarterly return on equity is -23.69%, with the most recent change of +0.92% (+3.74%) on September 30, 2024.
- Over the past year, DNTH quarterly ROE has increased by +10.52% (+30.75%).
- DNTH quarterly ROE is now at all-time high.
Performance
DNTH Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DNTH ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +64.4% | +30.8% |
| 3 y3 years | -147.3% | +30.8% |
| 5 y5 years | -147.3% | +30.8% |
DNTH ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -147.3% | +64.4% | at high | +51.7% |
| 5 y | 5-year | -147.3% | +64.4% | at high | +51.7% |
| alltime | all time | -147.3% | +64.4% | at high | +51.7% |
Dianthus Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -23.69%(-3.7%) |
| Jun 2024 | - | -24.61%(-2.8%) |
| Mar 2024 | - | -25.31%(-18.5%) |
| Dec 2023 | -35.92% | -31.04%(-9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -34.21%(-30.3%) |
| Jun 2023 | - | -49.05%(+44.6%) |
| Mar 2023 | - | -33.93%(+39.6%) |
| Dec 2022 | -100.97%(-232.9%) | -24.30% |
| Dec 2021 | 76.00% | - |
FAQ
- What is Dianthus Therapeutics annual return on equity?
- What is the all time high annual ROE for Dianthus Therapeutics?
- What is Dianthus Therapeutics annual ROE year-on-year change?
- What is Dianthus Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Dianthus Therapeutics?
- What is Dianthus Therapeutics quarterly ROE year-on-year change?
What is Dianthus Therapeutics annual return on equity?
The current annual ROE of DNTH is -35.92%
What is the all time high annual ROE for Dianthus Therapeutics?
Dianthus Therapeutics all-time high annual return on equity is 76.00%
What is Dianthus Therapeutics annual ROE year-on-year change?
Over the past year, DNTH annual return on equity has changed by +65.05% (+64.43%)
What is Dianthus Therapeutics quarterly return on equity?
The current quarterly ROE of DNTH is -23.69%
What is the all time high quarterly ROE for Dianthus Therapeutics?
Dianthus Therapeutics all-time high quarterly return on equity is -23.69%
What is Dianthus Therapeutics quarterly ROE year-on-year change?
Over the past year, DNTH quarterly return on equity has changed by +10.52% (+30.75%)